Mrv1909 11291917032D 9 8 0 0 0 0 999 V2000 1.4289 1.0312 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.2062 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 -0.2062 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 0.7144 -1.0312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7144 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 0.2062 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -0.2062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2 1 2 0 0 0 0 3 2 1 0 0 0 0 4 2 1 0 0 0 0 4 5 1 1 0 0 0 6 4 1 0 0 0 0 7 6 1 0 0 0 0 8 7 1 0 0 0 0 9 8 1 0 0 0 0 M END > DBMET00506 > drugbank > CSCC[C@H](N)C(O)=O > InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1 > FFEARJCKVFRZRR-BYPYZUCNSA-N > C5H11NO2S > 149.211 > 149.051049291 > 3 > 20 > 15.504513637142049 > 1 > 2 > 0 > 0 > (2S)-2-amino-4-(methylsulfanyl)butanoic acid > -1.85 > -2.189326616871282 > -0.80 > 0 > 0 > 0 > 2.5319210041042344 > 9.502323343916569 > 63.31999999999999 > 37.586000000000006 > 4 > 1 > 2.39e+01 g/l > palladium(2+) (4S,5S,14R,15R)-10-acetyl-4-(2-carboxyethyl)-15-ethyl-2-(2-methoxy-2-oxoethyl)-5,9,14,19-tetramethyl-20-[(2-sulfoethyl)carbamoyl]-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3(24),6,8,10,12,16(22),17,19-nonaene-21,23-diide > 0 > DBMET00506 > Methionine $$$$